Hans Thomas Axelsson

Hans Thomas Axelsson currently works at Vitrolife Sweden AB, as Chief Executive Officer, AzAj AB, as Chief Executive Officer, Azaj Medical AB, as Chief Executive Officer, and Vitrolife Ltd., as Director from 2012.
Mr. Axelsson also formerly worked at Vitrolife AB, as Chief Executive Officer from 2011 to 2023, Artema Medical AB, as Chief Executive Officer, Stille AB, as Chief Executive Officer, Xelex AB, as Chief Executive Officer, SBL Vaccin AB, as Chairman, Millicore AB, as Chairman, Neoventa Medical AB, as Chairman, Airsonett AB, as Chairman, Medtentia AB, as Chairman, QuickCool AB, as Chairman, Dipylon Medical AB, as Chairman, Oricane AB, as Chairman, Neoventa Holding AB, as Chairman, Avidicare AB, as Chairman, Airsonett Holding AB, as Chairman, Airsonett Intressenter AB, as Chairman, Abato Eglyar AB, as Chairman, Medivir AB, as Director, MedCap AB, as Independent Director, Ericsson AB, as Director & Project Manager, Baxter Medical AB, as Director-Business Unit, and Sinch Operator Software AB, as Chief Executive & Operating Officer from 2009 to 2012.
Mr. Axelsson received his graduate degree from Faculty of Engineering, Lund University and undergraduate degree from Linköping Institute of Technology.